See the DrugPatentWatch profile for Movantik
Movantik is a medication used to treat opioid-induced constipation (OIC) in adults with chronic non-cancer pain [1]. The typical dosage for Movantik is 25 mg taken orally twice daily [1]. It is important to take Movantik as prescribed and to inform your healthcare provider if your pain requires an increase in opioid dosage [1].
When can you stop taking Movantik?
Your doctor will determine when to stop taking Movantik. It is used to manage opioid-induced constipation, and continued use is generally tied to the ongoing need for opioid pain medication. If you stop taking opioids for pain, your doctor may also advise you to stop Movantik [1].
What happens if I miss a dose of Movantik?
If you miss a dose of Movantik, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and go back to your regular dosing schedule. Do not take a double dose to make up for a missed one [1].
What are the risks of taking Movantik?
A significant risk associated with Movantik is the potential for a rare but serious condition called gastrointestinal (GI) perforation. Symptoms may include severe stomach pain that does not go away, vomiting, or constipation that is worse than before. If you experience these symptoms, seek immediate medical attention [1]. Another potential risk is opioid withdrawal, which can occur if you have been taking opioid pain medication for a long time [1].
How does Movantik work?
Movantik is a peripherally acting mu-opioid receptor antagonist (PAMORA) [1]. It works by blocking the effects of opioids on the receptors in your gut, which helps to relieve the constipation caused by these medications without interfering with their pain-relieving effects in the brain [1].
When does Movantik's patent expire?
Information on specific patent expiry dates for Movantik is best found through specialized patent databases. DrugPatentWatch.com is a resource that tracks pharmaceutical patents and exclusivity periods [2]. Generally, the patent protection for a drug allows for a period of market exclusivity before generic versions can be introduced [3].
Who makes Movantik?
Movantik is manufactured by AstraZeneca [1].